Chemotherapy News and Research

Latest Chemotherapy News and Research

Mysterious molecule Yin Yang may fuel tumor growth in breast cancer

Scientists have unveiled clues about a mysterious molecule called Yin Yang1 - and revealed it may fuel tumor growth in breast cancer.

23 Jul 2018

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.

23 Jul 2018

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

20 Jul 2018

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale School of Medicine.

20 Jul 2018

Genetic sequencing reveals new clues to aggressiveness of prostate cancer

Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common.

20 Jul 2018

Study uncovers new protein complex that shields broken DNA ends

Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

19 Jul 2018

Understanding triple-negative breast cancer to develop better treatments

Breast cancer affects 1 in 8 women in her lifetime. Among the various types, triple-negative breast cancer is the rarest and most aggressive – affecting about 15 percent of breast cancer patients. It is also the least studied.

19 Jul 2018

Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients

HORIBA UK Ltd, Medical announces the publication of two studies successfully evaluating the use of its Yumizen H500 hematology analyzer for point-of-care testing to enhance the care of oncology patients.

From HORIBA Medical 17 Jul 2018

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

Patients whose blood cancers have failed to respond to repeated rounds of chemotherapy may be candidates for a new type of gene therapy that could send their cancers into remission for years.

17 Jul 2018

3D modeling of drug resistance could lead to more effective cancer treatment

The National Institutes of Health is funding the research of a University of Akron scientist that could lead to more effective cancer treatment.

16 Jul 2018

Testosterone effective at fighting cachexia in cancer patients, research shows

Many cancer patients suffer from a loss of body mass known as cachexia. Approximately 20 percent of cancer-related deaths are attributed to the syndrome of cachexia, which in cancer patients is often characterized by a rapid and/or severe loss of fat and skeletal muscle.

13 Jul 2018

Study finds wide variations in follow-up imaging for women with non-metastatic breast cancer

Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UC San Francisco.

13 Jul 2018

New technique measures how well cancer drugs reach their targets

Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body.

13 Jul 2018

Deadlier subtype of metastatic prostate cancer found to be common than previously thought

A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large number of these cancers – about 17 percent – belong to a deadlier subtype of metastatic prostate cancer.

12 Jul 2018

Scientists deliver nano-size packets of genetic code to treat brain tumors in mice

In a "proof of concept" study, scientists at Johns Hopkins Medicine say they have successfully delivered nano-size packets of genetic code called microRNAs to treat human brain tumors implanted in mice.

12 Jul 2018

Insurance gains improve outcome for young women with gynecologic cancers

The gains in insurance coverage with the Patient Protection and Affordable Care Act (ACA) have already translated into improved health for young women with gynecologic cancers, who are getting diagnosed at earlier stages of their disease because of ACA benefits.

12 Jul 2018

Researchers elucidate role of mutations in deadly brain cancer

Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center have discovered how different mutations in a specific gene help drive glioblastoma, the most lethal form of brain cancer.

11 Jul 2018

Geography may be destiny in end-of-life care for cancer patients

When it comes to how much end-of-life care a patient with cancer receives, geography may, indeed, be destiny, according to new research led by Harvard Medical School that found striking differences in terminal care across different parts of the country.

10 Jul 2018

Altitude sickness drug may offer significant gains for patients with glioblastoma

A drug used to treat altitude sickness -- as well as glaucoma, epilepsy, heart failure and seizures -- may also offer significant gains for patients with a fast-growing brain tumor known as glioblastoma, according to a study published July 4, 2018, in the journal Science Translational Medicine.

10 Jul 2018

Study assesses effectiveness of chlorhexidine in preventing bacteremia after tooth extraction

A large number of bacteria are present in human mouths and may pass into the blood when procedures such as the removal of a tooth are carried out. Chlorhexidine mouthwashes have a powerful antimicrobial effect, but there are opposing positions on its use in these cases.

9 Jul 2018

Chemotherapy News and Research

Latest Chemotherapy News and Research

Mysterious molecule Yin Yang may fuel tumor growth in breast cancer

Pfizer announces FDA approval of biosimilar to Neupogen

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Replacing conventional cancer treatment with complementary therapy linked to increased risk of death

Genetic sequencing reveals new clues to aggressiveness of prostate cancer

Study uncovers new protein complex that shields broken DNA ends

Understanding triple-negative breast cancer to develop better treatments

Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients

Staggering prices slow insurers’ coverage of CAR-T cancer therapy

3D modeling of drug resistance could lead to more effective cancer treatment

Testosterone effective at fighting cachexia in cancer patients, research shows

Study finds wide variations in follow-up imaging for women with non-metastatic breast cancer

New technique measures how well cancer drugs reach their targets

Deadlier subtype of metastatic prostate cancer found to be common than previously thought

Scientists deliver nano-size packets of genetic code to treat brain tumors in mice

Insurance gains improve outcome for young women with gynecologic cancers

Researchers elucidate role of mutations in deadly brain cancer

Geography may be destiny in end-of-life care for cancer patients

Altitude sickness drug may offer significant gains for patients with glioblastoma

Study assesses effectiveness of chlorhexidine in preventing bacteremia after tooth extraction

Cancer Research - Second Edition eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in